SPO Medical Reports 2007 Sales: Growth of 35% Compar...( Sales Growth Reflects Increased ...),Health

Sales Growth Reflects Increased Market Penetration and Entry Into

Professional Medical Markets

NEW YORK, March 25 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it has filed its Annual Report on Form 10-KSB for the year ended December 31, 2007.

Gross revenues of US$5.01 Million were recorded in 2007, a 35% increase on the gross revenues for 2006 of US$3.71 Million. The 2007 revenues reflected increasing sales of SPO Medical's PulseOx 5500(TM) and Check Mate(TM) and the initial entry in to the professional medical market with the first sales of the PulseOx 7500(TM), a pre-screening tool for monitoring Sleep Apnea.

"SPO Medical is delighted to report increased annual sales and market penetration during 2007," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "We have now sold in excess of 125,000 SPO Medical pulse oximeters and have increased our distribution base to 38 countries. In 2007, we further expanded our professional medical market product portfolio with the recent release of two new professional products: the finger PulseOx 6000(TM) and the hand-held PulseOx 6100(TM). We're especially optimistic about their sales prospects as they leverage our reputation for quality, low maintenance and environmentally efficient products in the professional medical market."

Mr. Braunold concluded, "Despite the current general economic global atmosphere, SPO Medical is looking forward to market growth opportunities during 2008 as we build upon our 2007 achievements, further increase our worldwide distribution base and grow our portfolio of products. We believe achievement of these strategic goals will contribute to increased value for SPO Medical shareholders."

A more detailed description of the financial results and financial statements are contain
'/>"/>